News | Breast Density | April 06, 2017

Colorado Enacts Dense Breast Tissue Reporting Bill

Beginning Oct. 1, 2017, mammography facilities will be required to notify patients if they have dense fibroglandular breast tissue, warn them of increased cancer risk

Colorado, fibroglandular breast density, reporting bill, mammography, breast cancer

April 6, 2017 — Colorado Gov. John Hickenlooper signed the Dense Breast Tissue Reporting Bill (SB17-142) on April 6, adding to the growing list of density reporting laws across the country. The signing makes Colorado the 29th state to enact some form of legislation requiring mammography facilities to notify patients about the impact of fibroglandular breast density on cancer detection and risk.

The language of SB17-142 requires mammography providers to include a notification in the report provided to the patient if the patient is found to have dense fibroglandular breast tissue. The notice must also inform the patient that while common, dense breast tissue can make it more difficult to evaluate the results of the mammogram and it is associated with an increased risk of breast cancer.

The bill was introduced in the Colorado Legislature by Sen. Angela Williams and sponsored in the House by Rep. Jessie Danielson.  The Colorado Breast Density Coalition actively advocated for the law.

“This is a victory for Colorado women,” said Williams.  "Now all women in Colorado will have the same information as their doctors."  

Danielson added, "This law encourages patients to discuss with healthcare providers screening options that are personalized to a patient with dense breast tissue. It is one solution to increase the early detection of breast cancer."

The law is effective on Oct. 1, 2017.  Currently, New Mexico, Iowa and Kentucky have breast density reporting bills awaiting governors' action.

For more information on dense breast tissue, read the article "Mammographic Breast Density — What It Means."

For more information: www.areyoudense.org

Related Content

Results of Journal of the American College of Surgeons study should reassure breast cancer patients who experienced surgical postponements due to COVID-19 pandemic

Association between Time to Operation and Pathological Stage in DCIS & ER+ Breast Cancer. Courtesy of American College of Surgeons

News | Women's Health | August 07, 2020
August 7, 2020 — A new br...
Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of mammography systems to Hologic’s state-of-the-art imaging technology
News | Breast Imaging | August 06, 2020
August 6, 2020 — RadNet, Inc., a national leader in providing hig
Hologic, Inc. launched the Back to Screening campaign encouraging women to schedule their annual mammograms now that healthcare facilities across the nation are re-opening their doors following closures due to the COVID-19 pandemic.

Nine-time GRAMMY Award winner and breast cancer survivor Sheryl Crow has served as the spokesperson for Hologic’s Genius 3D Mammography exam for nearly five years.

News | Breast Imaging | August 03, 2020
August 3, 2020 — Hologic, Inc. launched the Back to Screening campaign encouraging women to schedule their ann
It covers every major modality, including breast imaging/mammography, fixed and portable C-arms (cath, IR/angio, hybrid, OR), CT, MRI, nuclear medicine, radiographic fluoroscopy, ultrasound and X-ray
News | Radiology Imaging | July 29, 2020
July 29, 2020 — IMV Medical Information, part of Scien...
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system.
News | Breast Imaging | July 08, 2020
July 8, 2020 — Hologic, Inc. announced he U.S.
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane